BMEA Stock Analysis: Buy, Sell, or Hold?
BMEA - Biomea Fusion, Inc. Common Stock
$1.37
0.01 (0.74%)
▲
5d:
-27.51%
30d:
-8.05%
90d:
+22.32%
WAIT
LOW Confidence
Analysis Updated: May 1, 2026 12:00 AM ET
Earnings: May 04, 2026
TODAY
Smart Money Accumulation
BMEA is down 29.4% this week, but smart money is accumulating calls. Top strike: $1.5 2026-07-17 with 2,507 OI. Call ratio: 85% View Scanner →
Strength: 10.0/10
Get Alerted When BMEA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: BMEA is down 27.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: BMEA is down 27.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: BMEA is currently trading at $1.37, which is considered slightly low relative to its 30-day fair value range of $1.36 to $1.94.
Technical Outlook: Technically, BMEA is in a uptrend. Immediate support is located at $1.32, while resistance sits at $2.24.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.33 (+435.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BMEA is in a uptrend. Immediate support is located at $1.32, while resistance sits at $2.24.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $7.33 (+435.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.36 -
$1.94
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 435.3% below Wall St target ($7.33)
- WARNING: Recommendation downgraded due to -27.5% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$1.36 -
$1.94
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.32
Resistance Level
$2.24
Current Trend
Uptrend
Technical data as of
May 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.29
Wall Street Target
$7.33
(+435.3%)
Share & Embed Analysis
Last updated: May 02, 2026 10:42 PM ET
Data refreshes hourly during market hours. Next update: 11:42 PM
Data refreshes hourly during market hours. Next update: 11:42 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BMEA showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Rainer M Erdtmann
BUY
30000 shares
2025-12-11
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$53 | 60 BUY |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$226 | 63 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 52 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 50 HOLD |
